Literature DB >> 4035357

Deficient vasoactive intestinal peptide innervation in the sweat glands of cystic fibrosis patients.

P Heinz-Erian, R D Dey, M Flux, S I Said.   

Abstract

The innervation of acini and ducts of eccrine sweat glands by immunoreactive, vasoactive intestinal peptide-containing nerve fibers was sharply reduced in seven patients with cystic fibrosis compared to eight normal subjects. The decrease in innervation by this neuropeptide, which has been shown to promote blood flow and the movement of water and chloride across epithelial surfaces in other systems, may be a basic mechanism for the decreased water content and relative impermeability of the epithelium to chloride and other ions that characterize cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4035357     DOI: 10.1126/science.4035357

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  14 in total

1.  Ion transport in cultured epithelia from human sweat glands: comparison of normal and cystic fibrosis tissues.

Authors:  D J Brayden; R J Pickles; A W Cuthbert
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

2.  Cutaneous blood flow and local sweating after systemic atropine administration.

Authors:  M A Kolka; L A Stephenson
Journal:  Pflugers Arch       Date:  1987-11       Impact factor: 3.657

Review 3.  Vasoactive intestinal peptide.

Authors:  S I Said
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

Review 4.  Cystic Fibrosis and the Nervous System.

Authors:  Leah R Reznikov
Journal:  Chest       Date:  2016-11-19       Impact factor: 9.410

5.  The gene encoding vasoactive intestinal peptide is located on human chromosome 6p21----6qter.

Authors:  I Gozes; R Avidor; Y Yahav; D Katznelson; C M Croce; K Huebner
Journal:  Hum Genet       Date:  1987-01       Impact factor: 4.132

6.  CFTR-deficient pigs display peripheral nervous system defects at birth.

Authors:  Leah R Reznikov; Qian Dong; Jeng-Haur Chen; Thomas O Moninger; Jung Min Park; Yuzhou Zhang; Jianyang Du; Michael S Hildebrand; Richard J H Smith; Christoph O Randak; David A Stoltz; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

7.  Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of humans.

Authors:  Lee Ann T Bennett; John M Johnson; Dan P Stephens; Adham R Saad; Dean L Kellogg
Journal:  J Physiol       Date:  2003-07-07       Impact factor: 5.182

8.  VIP antagonists enhance excitatory cholinergic neurotransmission in the human airway.

Authors:  H Aizawa; H Inoue; M Shigyo; S Takata; H Koto; K Matsumoto; N Hara
Journal:  Lung       Date:  1994       Impact factor: 2.584

9.  Measurement of intracellular mediators in enterocytes isolated from jejunal biopsy specimens of control and cystic fibrosis patients.

Authors:  B W Hitchin; P R Dobson; B L Brown; J Hardcastle; P T Hardcastle; C J Taylor
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

10.  Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis.

Authors:  Jae Young Choi; Nam Soo Joo; Mauri E Krouse; Jin V Wu; Robert C Robbins; Juan P Ianowski; John W Hanrahan; Jeffrey J Wine
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.